284 related articles for article (PubMed ID: 17467133)
1. High clozapine concentrations in leukocytes in a patient who developed leukocytopenia.
Bergemann N; Abu-Tair F; Aderjan R; Kopitz J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1068-71. PubMed ID: 17467133
[TBL] [Abstract][Full Text] [Related]
2. [Haematological abnormalities during treatment with atypical antipsychotics].
Thome J; Kopf D
Psychiatr Prax; 2005 May; 32(4):167-71. PubMed ID: 15852208
[TBL] [Abstract][Full Text] [Related]
3. Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring.
Schulte P
Ann Pharmacother; 2006 Apr; 40(4):683-8. PubMed ID: 16595571
[TBL] [Abstract][Full Text] [Related]
4. Clozapine: the commitment to patient safety.
Alphs LD; Anand R
J Clin Psychiatry; 1999; 60 Suppl 12():39-42. PubMed ID: 10372610
[TBL] [Abstract][Full Text] [Related]
5. The incidence of clozapine-induced leukopenia in patients with schizophrenia at Srinagarind Hospital.
Maskasame S; Krisanaprakornkit T; Khiewyoo J
J Med Assoc Thai; 2007 Oct; 90(10):2175-80. PubMed ID: 18041439
[TBL] [Abstract][Full Text] [Related]
6. Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
Herceg M; Muzinić L; Jukić V
Psychiatr Danub; 2010 Mar; 22(1):85-9. PubMed ID: 20305597
[TBL] [Abstract][Full Text] [Related]
7. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS?
Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J
Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201
[TBL] [Abstract][Full Text] [Related]
8. [Patient knowledge regarding Clozapine-induced agranulocytosis].
Haberfellner EM; Rittmannsberger H
Psychiatr Prax; 2006 May; 33(4):194-6. PubMed ID: 16680627
[No Abstract] [Full Text] [Related]
9. Hematological adverse events in clozapine-treated children and adolescents.
Gerbino-Rosen G; Roofeh D; Tompkins DA; Feryo D; Nusser L; Kranzler H; Napolitano B; Frederickson A; Henderson I; Rhinewine J; Kumra S
J Am Acad Child Adolesc Psychiatry; 2005 Oct; 44(10):1024-31. PubMed ID: 16175107
[TBL] [Abstract][Full Text] [Related]
10. Testing the hypothesis that selenium deficiency is a risk factor for clozapine-induced agranulocytosis in rats.
Ip J; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):874-8. PubMed ID: 18380444
[TBL] [Abstract][Full Text] [Related]
11. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
12. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States.
Alvir JM; Lieberman JA; Safferman AZ; Schwimmer JL; Schaaf JA
N Engl J Med; 1993 Jul; 329(3):162-7. PubMed ID: 8515788
[TBL] [Abstract][Full Text] [Related]
13. [Clozapine screening: white bloodcell counts no longer sufficient].
Cohen D;
Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
[TBL] [Abstract][Full Text] [Related]
14. [Toxic plasma concentration of clozapine in inflammatory processes].
van Gool AR; de Jong MH; Verhoeven WM
Tijdschr Psychiatr; 2010; 52(11):791-6. PubMed ID: 21064022
[TBL] [Abstract][Full Text] [Related]
15. Haematological side effects of clozapine: patient characteristics.
Miller PR; Cutten AE
N Z Med J; 1997 Apr; 110(1041):125-7. PubMed ID: 9140414
[TBL] [Abstract][Full Text] [Related]
16. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
Combs MD; Perry PJ; Bever KA
Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
[TBL] [Abstract][Full Text] [Related]
17. Testing the hypothesis that vitamin C deficiency is a risk factor for clozapine-induced agranulocytosis using guinea pigs and ODS rats.
Ip J; Wilson JX; Uetrecht JP
Chem Res Toxicol; 2008 Apr; 21(4):869-73. PubMed ID: 18380445
[TBL] [Abstract][Full Text] [Related]
18. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
19. [Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].
Güzelcan Y; Scholte WF
Tijdschr Psychiatr; 2006; 48(4):295-302. PubMed ID: 16955993
[TBL] [Abstract][Full Text] [Related]
20. [Relationship between clozapine plasma levels and withdrawal symptoms].
Berecz R; de la Rubia Martínez A; Norberto Gamero MJ; Gutiérrez Casares JR; Glaub T; Degrell I; Llerena A
Actas Esp Psiquiatr; 2002; 30(6):397-9. PubMed ID: 12487951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
